RENO, Nev., Jan. 11 /PRNewswire/ -- The Woodrow Wilson International
Center for Scholars today released a policy analysis of an industry that is
projected to top $1-trillion within a decade -- nanotechnology. The report
outlines a "menu of possibilities" for government action to deal with the
"adverse" effects of nanotechnology, and provides evidence that the author
says is relevant to determining what needs to be done to manage the industry.
As an independent creator and leading supplier of advanced ceramic
nanomaterials, Altair Nanotechnologies CEO Alan Gotcher can share his thoughts
on how this could include a facts based approach.
WHO: Alan J. Gotcher, Ph.D.
President and chief executive officer of Altair Nanotechnologies
WHY: Regulation of nanoparticles needs to be fact driven. In order to
get the facts, we need to stimulate both increased federal
investment in research and development to better understand the
various families/classes of nanomaterials, and the development of
strong corporate commitment to good nanotechnology stewardship.
Altair Nanotechnologies is already on the road to strong corporate
stewardship, with an ongoing partnership to study environmental
and occupational safety with the National Institute for
Occupational Safety and Health.
HOW: Contact Sanda Pecina (202-367-1622, email@example.com) or
Matt Taylor (202-367-1626) to schedule an interview or background
ABOUT ALTAIR NANOTECHNOLOGIES INC.
Altairnano is a leading supplier and innovator of advanced ceramic
nanomaterial technology. Based in Reno, Nevada, Altairnano has assembled a
unique team of materials scientists who, coupled in collaborative ventures
with industry partners and leading academic centers, have pioneered an array
of intellectual property and products. Altairnano's robust proprietary
technology platforms produce a variety of crystalline and non-crystalline
nanomaterials of unique structure, performance, quality and cost. The company
has scalable manufacturing capability to meet emerging nanomaterials demands.
Altairnano's two divisions, Life Sciences and Performance Materials, are
focused on applications where its nanotechnology may enable new high growth
markets. The Life Sciences division is pursuing market applications in
pharmaceuticals, drug delivery, dental materials and other medical markets.
The Performance Materials division is focused on market applications in
advanced materials for paints and coatings; air and water treatment and
alternative energy, including new lithium ion battery electrode materials. For
additional information on Altairnano and its nanomaterials, visit
SOURCE Altair Nanotechnologies Inc.